State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Disease, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Clinical Medical Research Center, The Second Clinical Medical College, Jinan University, Shenzhen People's Hospital, Shenzhen, China.
DNA Cell Biol. 2020 Apr;39(4):499-512. doi: 10.1089/dna.2019.5099. Epub 2020 Feb 18.
This research aims to investigate the immune-associated gene signature from databases to improve the prognostic value in hepatocellular carcinoma (HCC) by multidimensional methods using various bioinformatic methods. Fifty-one immune-associated genes were mined out, which were associated with clinical characters through univariate and multivariate Cox regression analyses, and 51 immune-associated genes could be well-divided HCC samples into high-risk and low-risk clusters. Next, we performed least absolute shrinkage and selection operator (LASSO) Cox regression method to reveal 18 immune-associated genes' signature and calculate risk score of each gene for receiver operating characteristic (ROC) analysis. Comparing with low-risk cluster, high-risk cluster had higher risk score with unfavorable prognosis. Then, multivariate Cox regression analysis showed that risk score of 18 immune-associated genes' signature was associated with tumor invasion and tumor-node-metastasis (TNM) stage. ROC analysis indicated combined TNM stage, and risk score performed more sensitive and specific than single TNM stage or risk score in survival prediction. Furthermore, Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis found that the pathways enriched in tumorigenesis were related to risk score, and those pathways could separate HCC samples into high and low clusters. In addition, the survival prediction of 18 immune-associated genes' signature was well validated in independent test data set, external data set, and Real-time Quantitative PCR (RT-qPCR) experiment. The 18 immune-associated genes' signature was constructed, which could be used in effective prediction of HCC prognosis.
本研究旨在通过多维方法,使用各种生物信息学方法,从数据库中挖掘免疫相关基因特征,以提高肝细胞癌(HCC)的预后价值。通过单变量和多变量 Cox 回归分析,挖掘出 51 个与临床特征相关的免疫相关基因,并将这些基因分为高风险和低风险两组。接下来,我们进行了最小绝对收缩和选择算子(LASSO)Cox 回归分析,以揭示 18 个免疫相关基因特征,并计算每个基因的风险评分,用于接受者操作特征(ROC)分析。与低风险组相比,高风险组的风险评分更高,预后更差。然后,多变量 Cox 回归分析表明,18 个免疫相关基因特征的风险评分与肿瘤侵袭和肿瘤-淋巴结-转移(TNM)分期有关。ROC 分析表明,联合 TNM 分期和风险评分比单独 TNM 分期或风险评分在生存预测中具有更高的敏感性和特异性。此外,京都基因与基因组百科全书(KEGG)分析发现,肿瘤发生相关的通路与风险评分有关,这些通路可以将 HCC 样本分为高风险和低风险两组。此外,18 个免疫相关基因特征的生存预测在独立测试数据集、外部数据集和实时定量 PCR(RT-qPCR)实验中得到了很好的验证。构建了 18 个免疫相关基因特征,可以有效预测 HCC 的预后。